Form 4: Roivant Sciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Ilan Oren, a Director of Roivant Sciences Ltd., reported a transaction in 2,378 shares of common stock on September 10, 2026.
Summary
- Tax/exercise-price withholding: disposed of 2,378 Common Shares at $40.94 ($97,355) on September 10, 2026; holds 118,626 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ilan Oren — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Tax/exercise-price withholding | Common Shares | 2,378 | $41 | $97.4K | 118,626 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Tax/exercise-price withholding (2,378 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., neutral, Ilan Oren
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.